Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Crural Closure improves Outcomes of Magnetic Sphincter Augmentation in GERD patients with Hiatal Hernia.

Schwameis K, Nikolic M, Castellano DGM, Steindl A, Macheck S, Riegler M, Kristo I, Zörner B, Schoppmann SF.

Sci Rep. 2018 May 9;8(1):7319. doi: 10.1038/s41598-018-24322-1.

2.

Lower extremity outcome measures: considerations for clinical trials in spinal cord injury.

Bolliger M, Blight AR, Field-Fote EC, Musselman K, Rossignol S, Barthélemy D, Bouyer L, Popovic MR, Schwab JM, Boninger ML, Tansey KE, Scivoletto G, Kleitman N, Jones LAT, Gagnon DH, Nadeau S, Haupt D, Awai L, Easthope CS, Zörner B, Rupp R, Lammertse D, Curt A, Steeves J.

Spinal Cord. 2018 Jul;56(7):628-642. doi: 10.1038/s41393-018-0097-8. Epub 2018 Apr 27. Review.

PMID:
29700477
3.

Results of Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease.

Schwameis K, Nikolic M, Morales Castellano DG, Steindl A, Macheck S, Kristo I, Zörner B, Schoppmann SF.

World J Surg. 2018 Apr 4. doi: 10.1007/s00268-018-4608-8. [Epub ahead of print]

PMID:
29619511
4.

Profiling walking dysfunction in multiple sclerosis: characterisation, classification and progression over time.

Filli L, Sutter T, Easthope CS, Killeen T, Meyer C, Reuter K, Lörincz L, Bolliger M, Weller M, Curt A, Straumann D, Linnebank M, Zörner B.

Sci Rep. 2018 Mar 21;8(1):4984. doi: 10.1038/s41598-018-22676-0.

5.

Positive effects of fampridine on cognition, fatigue and depression in patients with multiple sclerosis over 2 years.

Broicher SD, Filli L, Geisseler O, Germann N, Zörner B, Brugger P, Linnebank M.

J Neurol. 2018 May;265(5):1016-1025. doi: 10.1007/s00415-018-8796-9. Epub 2018 Feb 20.

PMID:
29464379
6.

Author response: Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis.

Filli L, Zörner B, Killeen T, Linnebank M.

Neurology. 2017 Sep 12;89(11):1200. doi: 10.1212/WNL.0000000000004379. Epub 2017 Sep 11. No abstract available.

PMID:
28894033
7.

Nogo-A antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathology.

Ineichen BV, Kapitza S, Bleul C, Good N, Plattner PS, Seyedsadr MS, Kaiser J, Schneider MP, Zörner B, Martin R, Linnebank M, Schwab ME.

Acta Neuropathol. 2017 Sep;134(3):423-440. doi: 10.1007/s00401-017-1745-3. Epub 2017 Jun 23.

8.

Minimum toe clearance: probing the neural control of locomotion.

Killeen T, Easthope CS, Demkó L, Filli L, Lőrincz L, Linnebank M, Curt A, Zörner B, Bolliger M.

Sci Rep. 2017 May 15;7(1):1922. doi: 10.1038/s41598-017-02189-y.

9.

Increasing cognitive load attenuates right arm swing in healthy human walking.

Killeen T, Easthope CS, Filli L, Lőrincz L, Schrafl-Altermatt M, Brugger P, Linnebank M, Curt A, Zörner B, Bolliger M.

R Soc Open Sci. 2017 Jan 25;4(1):160993. doi: 10.1098/rsos.160993. eCollection 2017 Jan.

10.

Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis.

Filli L, Zörner B, Kapitza S, Reuter K, Lörincz L, Weller D, Sutter T, Killeen T, Gruber P, Petersen JA, Weller M, Linnebank M.

Neurology. 2017 Feb 28;88(9):832-841. doi: 10.1212/WNL.0000000000003656. Epub 2017 Feb 1.

11.

Modulating Arm Swing Symmetry with Cognitive Load: A Window on Rhythmic Spinal Locomotor Networks in Humans?

Killeen T, Easthope CS, Filli L, Linnebank M, Curt A, Bolliger M, Zörner B.

J Neurotrauma. 2017 May 15;34(10):1897-1902. doi: 10.1089/neu.2016.4554. Epub 2016 Oct 12.

PMID:
27574966
12.

Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.

Zörner B, Filli L, Reuter K, Kapitza S, Lörincz L, Sutter T, Weller D, Farkas M, Easthope CS, Czaplinski A, Weller M, Linnebank M.

Mult Scler. 2016 Oct;22(11):1463-1475. Epub 2016 Jan 13.

13.

Bridging the gap: a reticulo-propriospinal detour bypassing an incomplete spinal cord injury.

Filli L, Engmann AK, Zörner B, Weinmann O, Moraitis T, Gullo M, Kasper H, Schneider R, Schwab ME.

J Neurosci. 2014 Oct 1;34(40):13399-410. doi: 10.1523/JNEUROSCI.0701-14.2014.

14.

Modern GERD treatment: feasibility of minimally invasive esophageal sphincter augmentation.

Schwameis K, Schwameis M, Zörner B, Lenglinger J, Asari R, Riegler FM, Schoppmann SF.

Anticancer Res. 2014 May;34(5):2341-8.

PMID:
24778041
15.

Chasing central nervous system plasticity: the brainstem's contribution to locomotor recovery in rats with spinal cord injury.

Zörner B, Bachmann LC, Filli L, Kapitza S, Gullo M, Bolliger M, Starkey ML, Röthlisberger M, Gonzenbach RR, Schwab ME.

Brain. 2014 Jun;137(Pt 6):1716-32. doi: 10.1093/brain/awu078. Epub 2014 Apr 15.

PMID:
24736305
16.

High-Impact, Self-Motivated Training Within an Enriched Environment With Single Animal Tracking Dose-Dependently Promotes Motor Skill Acquisition and Functional Recovery.

Starkey ML, Bleul C, Kasper H, Mosberger AC, Zörner B, Giger S, Gullo M, Buschmann F, Schwab ME.

Neurorehabil Neural Repair. 2014 Jul;28(6):594-605. doi: 10.1177/1545968314520721. Epub 2014 Feb 11.

PMID:
24519022
17.

Infusion of anti-Nogo-A antibodies in adult rats increases growth and synapse related proteins in the absence of behavioral alterations.

Craveiro LM, Weinmann O, Roschitzki B, Gonzenbach RR, Zörner B, Montani L, Yee BK, Feldon J, Willi R, Schwab ME.

Exp Neurol. 2013 Dec;250:52-68. doi: 10.1016/j.expneurol.2013.09.015. Epub 2013 Sep 25.

PMID:
24076004
18.

Back seat driving: hindlimb corticospinal neurons assume forelimb control following ischaemic stroke.

Starkey ML, Bleul C, Zörner B, Lindau NT, Mueggler T, Rudin M, Schwab ME.

Brain. 2012 Nov;135(Pt 11):3265-81. doi: 10.1093/brain/aws270.

PMID:
23169918
19.

Tail spasms in rat spinal cord injury: changes in interneuronal connectivity.

Kapitza S, Zörner B, Weinmann O, Bolliger M, Filli L, Dietz V, Schwab ME.

Exp Neurol. 2012 Jul;236(1):179-89. doi: 10.1016/j.expneurol.2012.04.023. Epub 2012 May 1.

PMID:
22569103
20.

Sustained efficacy of natalizumab in the treatment of relapsing-remitting multiple sclerosis independent of disease activity and disability at baseline: real-life data from a Swiss cohort.

Kallweit U, Jelcic I, Braun N, Fischer H, Zörner B, Schreiner B, Sokolov AA, Martin R, Weller M, Linnebank M.

Clin Neuropharmacol. 2012 Mar-Apr;35(2):77-80. doi: 10.1097/WNF.0b013e31824644e6.

21.

Motor deficits and recovery in rats with unilateral spinal cord hemisection mimic the Brown-Sequard syndrome.

Filli L, Zörner B, Weinmann O, Schwab ME.

Brain. 2011 Aug;134(Pt 8):2261-73. doi: 10.1093/brain/awr167. Epub 2011 Jul 13.

PMID:
21752788
22.

Profiling locomotor recovery: comprehensive quantification of impairments after CNS damage in rodents.

Zörner B, Filli L, Starkey ML, Gonzenbach R, Kasper H, Röthlisberger M, Bolliger M, Schwab ME.

Nat Methods. 2010 Sep;7(9):701-8.

PMID:
20836253
23.

Anti-Nogo on the go: from animal models to a clinical trial.

Zörner B, Schwab ME.

Ann N Y Acad Sci. 2010 Jun;1198 Suppl 1:E22-34. doi: 10.1111/j.1749-6632.2010.05566.x. Review.

PMID:
20590535
24.

Nogo-A antibodies and training reduce muscle spasms in spinal cord-injured rats.

Gonzenbach RR, Gasser P, Zörner B, Hochreutener E, Dietz V, Schwab ME.

Ann Neurol. 2010 Jul;68(1):48-57. doi: 10.1002/ana.22009.

PMID:
20582944
25.

Modulation of spinal reflex by assisted locomotion in humans with chronic complete spinal cord injury.

Bolliger M, Trepp A, Zörner B, Dietz V.

Clin Neurophysiol. 2010 Dec;121(12):2152-8. doi: 10.1016/j.clinph.2010.05.018. Epub 2010 Jun 15.

PMID:
20554473
26.

Outcome after incomplete spinal cord injury: central cord versus Brown-Sequard syndrome.

Wirz M, Zörner B, Rupp R, Dietz V.

Spinal Cord. 2010 May;48(5):407-14. doi: 10.1038/sc.2009.149. Epub 2009 Nov 10.

PMID:
19901956
27.

Functional and anatomical reorganization of the sensory-motor cortex after incomplete spinal cord injury in adult rats.

Ghosh A, Sydekum E, Haiss F, Peduzzi S, Zörner B, Schneider R, Baltes C, Rudin M, Weber B, Schwab ME.

J Neurosci. 2009 Sep 30;29(39):12210-9. doi: 10.1523/JNEUROSCI.1828-09.2009.

28.

Clinical algorithm for improved prediction of ambulation and patient stratification after incomplete spinal cord injury.

Zörner B, Blanckenhorn WU, Dietz V; EM-SCI Study Group, Curt A.

J Neurotrauma. 2010 Jan;27(1):241-52. doi: 10.1089/neu.2009.0901.

29.

Levodopa therapy in incomplete spinal cord injury.

Maric O, Zörner B, Dietz V.

J Neurotrauma. 2008 Nov;25(11):1303-7. doi: 10.1089/neu.2008.0583.

PMID:
19061374
30.

Reduced expression of brain-derived neurotrophic factor in mice deficient for pituitary adenylate cyclase activating polypeptide type-I-receptor.

Zink M, Otto C, Zörner B, Zacher C, Schütz G, Henn FA, Gass P.

Neurosci Lett. 2004 Apr 22;360(1-2):106-8.

PMID:
15082190
31.

Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior.

Chourbaji S, Hellweg R, Brandis D, Zörner B, Zacher C, Lang UE, Henn FA, Hörtnagl H, Gass P.

Brain Res Mol Brain Res. 2004 Feb 5;121(1-2):28-36.

PMID:
14969734
32.

Forebrain-specific trkB-receptor knockout mice: behaviorally more hyperactive than "depressive".

Zörner B, Wolfer DP, Brandis D, Kretz O, Zacher C, Madani R, Grunwald I, Lipp HP, Klein R, Henn FA, Gass P.

Biol Psychiatry. 2003 Nov 15;54(10):972-82.

PMID:
14625139
33.

Memory retrieval after contextual fear conditioning induces c-Fos and JunB expression in CA1 hippocampus.

Strekalova T, Zörner B, Zacher C, Sadovska G, Herdegen T, Gass P.

Genes Brain Behav. 2003 Feb;2(1):3-10.

Supplemental Content

Loading ...
Support Center